Trials / Completed
CompletedNCT00122837
A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 560 (planned)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical trial assessing duloxetine and comparator to placebo in patients who have generalized anxiety disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | |
| DRUG | venlafaxine | |
| DRUG | placebo |
Timeline
- Start date
- 2005-04-01
- Completion
- 2007-01-01
- First posted
- 2005-07-22
- Last updated
- 2007-10-18
Locations
22 sites across 8 countries: Argentina, Australia, Belgium, Canada, Mexico, Russia, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT00122837. Inclusion in this directory is not an endorsement.